Dr. Aslam Anis is an active health services researcher who consults widely with federal and provincial agencies, including Health Canada, the Public Health Agency of Canada, Industry Canada, the Canadian Medical Association, and various pharmaceutical manufacturers. To disseminate the policy implications of his research, he engages in a wide variety of knowledge transfer activities including participation on government panels, consumer associations and regulatory agencies. His work in the areas of Health Economics, Pharmacoeconomics, Pharmaco/Clinical Epidemiology, and Cost Effectiveness is based on an in-depth knowledge and familiarity with the various sources of health data in Canada and internationally.

Dr. Anis’ primary area of specialization is based on studying specific aspects of the pharmaceutical industry, especially the interface between government regulation and corporate behaviour. He has published articles on the impact of provincial drug plan regulatory policies on pharmaceutical firm behaviour, industry behaviour, and the cost implications of running provincial drug plans. He has also publications focusing on price regulation of pharmaceuticals and on the role pharmacoeconomic evaluations in reimbursement decision-making.

Dr. Anis is a member of several scholarly and peer review committees. He is a member of the Research Advisory Council of the Michael Smith Foundation for Health Research and The Canadian HIV/AIDS Research Advisory Committee at the Canadian Institutes of Health Research.